Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phase I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1

1 Sept 2004

Abstract excerpt

A phase I/II trial of a candidate vaccine to prevent HIV infection was carried out in Bangkok, Thailand, testing AIDSVAX B/E (VaxGen, Inc., Brisbane, CA), a bivalent subunit vaccine prepared by combining recombinant gp120 from a subtype B virus (HIV-1MN) with gp120 from a subtype E virus (HIV-1A244) in alum adjuvant. The studies provide human data on the immunogenicity of various dose combination of non-subtype B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to HIV Research and Treatment
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15319676
DOI: 10.1097/01.qai.0000136091.72955.4b

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Phase I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1PMID 15319676Read ↗

Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand.Semantic proximity Read ↗

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate VaccineSemantic proximity Read ↗

Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.Semantic proximity Read ↗

Retroviral vaccines: challenges for the developing world.Semantic proximity Read ↗

Review of preventative HIV vaccine clinical trials in South AfricaSemantic proximity Read ↗

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.Semantic proximity Read ↗

[Designing an effective AIDS vaccine: strategies and current status].Semantic proximity Read ↗

Designing multivalent immunogens for alphavirus vaccine optimizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.